This HTML5 document contains 138 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
phttp://www.wikidata.org/prop/
wikibasehttp://wikiba.se/ontology#
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n13http://dx.doi.org/10.1038/
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
n10https://scigraph.springernature.com/pub.10.1038/
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q53548858
rdf:type
wikibase:Item
schema:description
article scientifique наукова стаття, опублікована в червні 2007 article científic bài báo khoa học articolo scientifico artikull shkencor บทความทางวิทยาศาสตร์ article scientific επιστημονικό άρθρο bilimsel makale videnskabelig artikel artigo científico 2007年學術文章 научни чланак vitskapeleg artikkel scientific article published on 4 June 2007 2007年学术文章 tieteellinen artikkeli 2007年学术文章 artículo científico publicado en 2007 2007년 논문 scientific article published on 4 June 2007 artículu científicu 2007年學術文章 wissenschaftlicher Artikel scientific article published on 4 June 2007 artikulong pang-agham 2007年学术文章 2007年學術文章 научна статия ৪ জুন ২০০৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2007年学术文章 vedecký článok teaduslik artikkel 2007 nî lūn-bûn vědecký článek scienca artikolo مقالة علمية نشرت في 4 يونيو 2007 articol științific 2007年學術文章 სამეცნიერო სტატია 2007年学术文章 vetenskaplig artikel 2007年學術文章 artikel ilmiah artigo científico מאמר מדעי wetenschappelijk artikel научни чланак 2007年学术文章 2007 թվականի հունիսի 4-ին հրատարակված գիտական հոդված мақолаи илмӣ научная статья artigo científico tudományos cikk vitenskapelig artikkel 2007年の論文 naučni članak artykuł naukowy
p:P577
wds:Q53548858-B6FC0DC1-03E5-4B1C-A5D0-EEE5B87D86F7
wdt:P577
2007-06-04T00:00:00Z
p:P407
wds:Q53548858-E6D92AFB-CBFD-4796-97A8-58BB29945288
wdt:P407
wd:Q1860
p:P2888
wds:Q53548858-EB0E5F0D-CFE1-4CFE-9EDF-14E67CDD400B
wdt:P2888
n10:sj.onc.1210514
p:P2860
wds:Q53548858-03608C1E-891D-4BAC-9CCD-84B19D5AB9B5 wds:Q53548858-44AE96E1-BA49-4E40-9F63-B6F832C0EBF9 wds:Q53548858-478D36FF-0487-41E8-89DF-2F21A3E999DA wds:Q53548858-58FC2E55-73F3-495E-A514-B41FF6A540FA wds:Q53548858-2C703EA3-4161-47AA-8E5F-8421E1709BF2 wds:Q53548858-A37D2559-214C-47D7-B3EF-42673B10F3D2 wds:Q53548858-AD9F005E-2E3A-4398-9235-AF867283B54B wds:Q53548858-63227C40-D2A2-4DF4-A0CC-E1CB1222CC1A wds:Q53548858-8EF74BE3-87BB-444E-ABC5-98B579986EDF wds:Q53548858-D6C60FEB-4CC7-4515-9542-A62C41A0CC1C wds:Q53548858-DEC7CCB2-0E8F-48CF-A552-F19B9539B8B8 wds:Q53548858-BE13DB37-A2E1-487C-AB25-4F48B699B9A7 wds:Q53548858-C88171FB-53CB-45F5-825E-82910C095C93 wds:Q53548858-08CC5C8F-30A3-4514-BA97-0C4E26C5421A wds:Q53548858-185E8544-CEB5-4ED9-8AAF-136744CD0E7C wds:Q53548858-1865948C-FD1E-49B0-BA34-20D36AED7702 wds:Q53548858-199B8C71-F927-4A3E-9E8A-5B4BFE7FBAE0
wdt:P2860
wd:Q35110235 wd:Q40837411 wd:Q35667471 wd:Q53941920 wd:Q36254982 wd:Q34493162 wd:Q40399357 wd:Q37278002 wd:Q24319163 wd:Q34290272 wd:Q24322918 wd:Q47233081 wd:Q40323722 wd:Q42801762 wd:Q28141376 wd:Q24317715 wd:Q33739273
p:P2093
wds:Q53548858-C34CF885-8A90-421C-970D-0699F1CB9353 wds:Q53548858-BDB89BED-93B1-436C-B7A1-3E62110F1943 wds:Q53548858-F3B50EE3-DCF9-4411-B96B-37767D409FCD wds:Q53548858-2326FCA8-D2C2-410C-9BE2-EF739B5A33CD wds:Q53548858-2154D08F-7955-4413-B0F3-0FDBE59913AD wds:Q53548858-216D7AE7-3F83-4BBD-9B65-D9E482A55413
wdt:P2093
Glaros S Muchardt C Cirrincione GM Michael CW Kleer CG Reisman D
rdfs:label
The reversible epigenetic silencing of BRM: implications for clinical targeted therapy. The reversible epigenetic silencing of BRM: implications for clinical targeted therapy.
skos:prefLabel
The reversible epigenetic silencing of BRM: implications for clinical targeted therapy. The reversible epigenetic silencing of BRM: implications for clinical targeted therapy.
schema:name
The reversible epigenetic silencing of BRM: implications for clinical targeted therapy. The reversible epigenetic silencing of BRM: implications for clinical targeted therapy.
p:P1476
wds:Q53548858-FAEFD96D-CD12-4A84-9BE8-7E3FC25A14C3
wdt:P1476
The reversible epigenetic silencing of BRM: implications for clinical targeted therapy.
p:P304
wds:Q53548858-EA1F97E3-8EC7-4040-8BDB-B89FC3EB7405
wdt:P304
7058-7066
p:P31
wds:Q53548858-F3005717-E26E-4E5E-A3BD-33E53EA67F1C
wdt:P31
wd:Q13442814
p:P698
wds:Q53548858-4C6E8158-DCCE-46E8-9D1B-7475A2F63849
wdtn:P698
n12:17546055
wdt:P698
17546055
p:P1433
wds:Q53548858-E8AB3C0A-7B5F-4FB9-8C6C-FB5E50EA75EA
wdt:P1433
wd:Q1568657
p:P433
wds:Q53548858-8E3A378F-6A29-434B-AF2D-CE6D097FD3DA
p:P478
wds:Q53548858-08A3240D-4094-4003-A222-38DF434A2EAC
wdt:P433
49
wdt:P478
26
p:P356
wds:Q53548858-BAB2BA65-1075-42A1-80D7-C37AB0B8509F
wdtn:P356
n13:SJ.ONC.1210514
wdt:P356
10.1038/SJ.ONC.1210514
p:P5875
wds:Q53548858-719EAFF6-9444-4B3C-BE56-3C3999BDB644
wdt:P5875
6290602